“We do not stand on the sidelines. We are in the field, working with researchers to make real progress for patients.”
— Lynn Matrisian, PhD, MBA,
Chief Science Officer, Pancreatic Cancer Action Network
As part of our strategic approach to double survival by 2020, our Scientific and Medical Affairs team conducts independent and collaborative research. We disseminate important findings through prestigious journal publications, posters and presentations at international meetings. As a result, we are unifying and activating the research community with the urgency and passion to drive progress and improve patients’ lives around the world.
Research conducted by the Pancreatic Cancer Action Network’s Scientific and Medical Affairs team is shining a light on the needs of patients and caregivers to shape a brighter future. We are also learning from past efforts to ensure that the field evolves. In doing so, we are holding ourselves and our public and private partners accountable to progress.
We are asking big questions that might otherwise go unaddressed without trusted voices like the Pancreatic Cancer Action Network actively participating in research.
Explore Our Research
Improving Clinical Trials
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review
JAMA Oncology, 2016.
The Past, Present, and Future of Pancreatic Cancer Clinical Trials
American Society of Clinical Oncology Educational Book, 2016.
Pancreatic Cancer Clinical Trials and Accrual in the United States
Journal of Clinical Oncology, 2013.
Private Funding for Pancreatic Cancer Research: More Than a Chip Shot.
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Cancer Research, 2014.
Understanding Patient and Caregiver Priorities
Patient and caregiver awareness of pancreatic cancer treatments and clinical trials
Gastrointestinal Oncology, 2016.
Pancreatic cancer: Patient and caregiver perceptions on diagnosis, psychological impact, and importance of support
Molecular Profiling with Know Your Tumor®
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer Cancer Biology & Therapy, 2016.
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Meet Our Scientific and Medical Leadership
Lola Rahib, PhD
Scientific Project Manager
Make a Gift Today